Paid Clinical Trials St. Louis
Discover 1,246 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74
Sponsor:
Sarepta Therapeutics, Inc.
Location:
Code:
NCT06597656
Conditions
Duchenne Muscular Dystrophy
Eligibility Criteria
Sex: Male
Age: 4 - 8
Healthy Volunteers: Not accepted
Interventions
delandistrogene moxeparvovec
Plasmapheresis
DiamydA Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
Sponsor:
Diamyd Medical AB
Location:
Code:
NCT05018585
Conditions
Type 1 Diabetes Mellitus
Eligibility Criteria
Sex: All
Age: 12 - 28
Healthy Volunteers: Not accepted
Interventions
Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Colecalciferol 2000 IU
Placebo
Interdisciplinary CareInterdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
Sponsor:
Washington University School of Medicine
Location:
Code:
NCT06549985
Conditions
Endometriosis
Pelvic Pain
Eligibility Criteria
Sex: Female
Age: 18 - 48
Healthy Volunteers: Not accepted
Interventions
PEEPS
Education
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
RRMMMMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
Sponsor:
Multiple Myeloma Research Consortium
Location:
Code:
NCT06171685
Conditions
Relapse Multiple Myeloma
Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Teclistamab Monotherapy
Teclistamab
Interested in new trials?
Get alerts for new trials in your area by subscribing now
NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF
Sponsor:
Jaeb Center for Health Research
Location:
Code:
NCT05639556
Conditions
Cystic Fibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMI and lean mass index from DXA
Anthropometric Measurements
Hand-grip strength
Six-minute walk Test
Sit-to-Stand Test
Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Location:
Code:
NCT06369285
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Recurrent Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alisertib
Endocrine therapy
Tied Tube TrialTied Tube Trial in Glaucoma Surgery
Sponsor:
Washington University School of Medicine
Location:
Code:
NCT05685485
Conditions
Glaucoma Eye
Ahmed Glaucoma Valve Implantation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Standard Implantation
Tied off Tube
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
Operative vs. Non-OperativeMulti-Center Adolescent Clavicle Fracture Trial: Operative Vs. Non-Operative Treatment
Sponsor:
Boston Children's Hospital
Location:
Code:
NCT04250415
Conditions
Clavicle Fracture
Eligibility Criteria
Sex: All
Age: 10 - 18
Healthy Volunteers: Not accepted
Interventions
Surgery